Wells Fargo & Company Takeda Pharmaceutical CO LTD Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Wells Fargo & Company holds 978,002 shares of TAK stock, worth $13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
978,002
Previous 871,667 12.2%
Holding current value
$13 Million
Previous $11.3 Million 23.21%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$13.0 - $15.08 $1.38 Million - $1.6 Million
106,335 Added 12.2%
978,002 $13.9 Million
Q2 2024

Aug 13, 2024
BUY
$12.6 - $13.67 $261,097 - $283,269
20,722 Added 2.44%
871,667 $11.3 Million
Q1 2024

May 10, 2024
BUY
$13.89 - $15.04 $1.06 Million - $1.15 Million
76,393 Added 9.86%
850,945 $11.8 Million
Q4 2023

Feb 09, 2024
BUY
$13.36 - $15.43 $170,420 - $196,825
12,756 Added 1.67%
774,552 $11.1 Million
Q3 2023

Nov 13, 2023
BUY
$15.03 - $16.32 $41,272 - $44,814
2,746 Added 0.36%
761,796 $11.8 Million
Q2 2023

Aug 15, 2023
SELL
$15.57 - $17.11 $2.11 Million - $2.32 Million
-135,409 Reduced 15.14%
759,050 $11.9 Million
Q1 2023

May 12, 2023
SELL
$15.28 - $16.48 $546,458 - $589,374
-35,763 Reduced 3.84%
894,459 $14.7 Million
Q4 2022

Feb 13, 2023
BUY
$12.42 - $15.62 $585,379 - $736,201
47,132 Added 5.34%
930,222 $14.5 Million
Q3 2022

Nov 14, 2022
BUY
$12.8 - $28.65 $113,804 - $254,727
8,891 Added 1.02%
883,090 $11.5 Million
Q2 2022

Aug 12, 2022
BUY
$13.12 - $15.03 $714,593 - $818,623
54,466 Added 6.64%
874,199 $12.3 Million
Q1 2022

May 16, 2022
SELL
$13.54 - $15.35 $13 Million - $14.7 Million
-956,805 Reduced 53.86%
819,733 $11.7 Million
Q4 2021

Feb 14, 2022
SELL
$13.17 - $16.4 $5.91 Million - $7.36 Million
-448,517 Reduced 20.16%
1,776,538 $24.2 Million
Q3 2021

Nov 15, 2021
SELL
$16.3 - $17.26 $710,712 - $752,570
-43,602 Reduced 1.92%
2,225,055 $36.4 Million
Q2 2021

Aug 16, 2021
SELL
$16.55 - $18.64 $4.15 Million - $4.67 Million
-250,614 Reduced 9.95%
2,268,657 $38.2 Million
Q1 2021

May 13, 2021
BUY
$16.71 - $19.9 $1.78 Million - $2.12 Million
106,576 Added 4.42%
2,519,271 $46 Million
Q4 2020

Feb 09, 2021
BUY
$15.39 - $18.97 $12.8 Million - $15.8 Million
833,987 Added 52.83%
2,412,695 $43.9 Million
Q3 2020

Nov 05, 2020
BUY
$17.1 - $19.19 $5.7 Million - $6.4 Million
333,298 Added 26.76%
1,578,708 $28.2 Million
Q2 2020

Aug 13, 2020
BUY
$14.59 - $19.5 $13.1 Million - $17.5 Million
896,489 Added 256.93%
1,245,410 $22.3 Million
Q1 2020

May 14, 2020
BUY
$13.02 - $20.31 $4.54 Million - $7.09 Million
348,921 New
348,921 $5.3 Million

Others Institutions Holding TAK

# of Institutions
338
Shares Held
73.8M
Call Options Held
1.96M
Put Options Held
165K
View Full List

About TAKEDA PHARMACEUTICAL CO LTD

TAK Quotes by TradingView
  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $41.3B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email